Crain’s Cleveland Business: Cleveland biotech company secures $2.7M in NIH funding

Lamassu Biotech, a company with its “second headquarters” in Cleveland, has received a $2.7 million grant from the National Institutes of Health (NIH).

The funds will help support the development of a novel treatment protocol for acute pancreatitis in canines. However, Lamassu leadership said the finding will benefit more than just man’s best friend and will help further research for human treatments, too.

CLICK HERE to read the full story.